De Lisle Partners LLP Sells 10,000 Shares of Nutrien Ltd. $NTR

Posted by Geri Gentry on Jun 13th, 2026

De Lisle Partners LLP lowered its position in shares of Nutrien Ltd. (NYSE:NTR – Free Report) by 23.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 32,000 shares of the company’s stock after selling 10,000 shares during the quarter. De Lisle Partners LLP’s holdings in Nutrien were worth $1,975,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Montag A & Associates Inc. boosted its position in Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock valued at $26,000 after acquiring an additional 320 shares during the last quarter. Sfam LLC bought a new stake in Nutrien during the fourth quarter valued at $37,000. Eastern Bank boosted its position in Nutrien by 133.0% during the fourth quarter. Eastern Bank now owns 699 shares of the company’s stock valued at $43,000 after acquiring an additional 399 shares during the last quarter. Harbour Investments Inc. boosted its position in Nutrien by 97.2% during the fourth quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock valued at $43,000 after acquiring an additional 347 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its position in Nutrien by 42.4% during the second quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock valued at $43,000 after acquiring an additional 219 shares during the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Price Performance

NTR stock opened at $67.65 on Friday. The stock has a market capitalization of $32.47 billion, a PE ratio of 13.78, a price-to-earnings-growth ratio of 0.60 and a beta of 0.60. The company’s 50-day moving average is $71.34 and its 200-day moving average is $69.17. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.24 and a quick ratio of 0.59. Nutrien Ltd. has a 1 year low of $53.03 and a 1 year high of $85.36.

Nutrien (NYSE:NTR – Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The business’s revenue was up 18.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.11 EPS. Equities research analysts expect that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Tuesday, June 30th. Nutrien’s dividend payout ratio is 44.81%.

Analyst Ratings Changes

A number of brokerages have commented on NTR. Oppenheimer upped their price target on shares of Nutrien from $80.00 to $82.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. UBS Group cut their price target on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating on the stock in a research report on Monday, May 11th. Barclays upped their price target on shares of Nutrien from $70.00 to $80.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. JPMorgan Chase & Co. upped their price target on shares of Nutrien from $78.00 to $80.00 and gave the company an “overweight” rating in a research report on Monday, May 11th. Finally, Jefferies Financial Group raised shares of Nutrien from a “hold” rating to a “buy” rating and increased their price objective for the stock from $74.00 to $96.00 in a research report on Thursday, March 12th. Eleven equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Nutrien currently has a consensus rating of “Moderate Buy” and an average price target of $81.71.

Check Out Our Latest Report on NTR

Nutrien Profile

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.